Curie.Bio

Curie.Bio is a Boston-based venture capital firm founded in 2022 by Alexis Borisy, Zach Weinberg. See contact routes.

About Curie.Bio

Curie.Bio is a Boston-based venture capital firm founded in 2022 by Alexis Borisy, Zach Weinberg, and Christoph Lengauer to help scientists launch biotech therapeutics companies. The firm operates as a founder-focused seed-stage investor combined with a therapeutics accelerator, investing primarily in early-stage companies developing assets with potential annual sales exceeding $1 billion across modalities like small molecules, antibodies, and gene therapies. Curie.Bio typically provides seed investments ranging from $7 million to $12 million and acts as an operating partner by embedding drug-development teams inside startups to ensure they reach clinical milestones. While the firm has tracked over 26 investments across 23 companies, it has not publicly disclosed specific named portfolio companies or therapeutics programs. The firm raised an initial $520 million fund in early 2023 and secured an additional $380 million in June 2024, bringing its total capital to nearly $1 billion, with a later reported total of $1.2 billion. Curie.Bio distinguishes itself by functioning as a “drug discovery co-pilot,” offering founders access to 50 drug hunte

Curie.Bio at a glance

Role
Managing Director
Location
Boston, Massachusetts, United States
Investor type
Venture Capital

Frequently asked about Curie.Bio

What does Curie.Bio invest in?
We have not verified a stated sector or stage focus for Curie.Bio (Boston, Massachusetts, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Curie.Bio?
Curie.Bio's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Curie.Bio headquartered?
Curie.Bio is based in Boston, Massachusetts, United States.

StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.

Investors similar to Curie.Bio (20)

Browse related investor lists (2)

Compare Curie.Bio (8)

Investors like Curie.Bio · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades